Cargando…

Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy

BACKGROUND: Colorectal cancer (CRC) is one of the most common malignant tumors globally, with high morbidity and mortality. Endoplasmic reticulum is a major organelle responsible for protein synthesis, processing, and transport. Endoplasmic reticulum stress (ERS) refers to the abnormal accumulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hufei, Li, Zhi, Tao, Yangbao, Ou, Suwen, Ye, Jinhua, Ran, Songlin, Luo, Kangjia, Guan, Zilong, Xiang, Jun, Yan, Guoqing, Wang, Yang, Ma, Tianyi, Yu, Shan, Song, Yanni, Huang, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566095/
https://www.ncbi.nlm.nih.gov/pubmed/37821882
http://dx.doi.org/10.1186/s12967-023-04547-z
_version_ 1785118846054563840
author Wang, Hufei
Li, Zhi
Tao, Yangbao
Ou, Suwen
Ye, Jinhua
Ran, Songlin
Luo, Kangjia
Guan, Zilong
Xiang, Jun
Yan, Guoqing
Wang, Yang
Ma, Tianyi
Yu, Shan
Song, Yanni
Huang, Rui
author_facet Wang, Hufei
Li, Zhi
Tao, Yangbao
Ou, Suwen
Ye, Jinhua
Ran, Songlin
Luo, Kangjia
Guan, Zilong
Xiang, Jun
Yan, Guoqing
Wang, Yang
Ma, Tianyi
Yu, Shan
Song, Yanni
Huang, Rui
author_sort Wang, Hufei
collection PubMed
description BACKGROUND: Colorectal cancer (CRC) is one of the most common malignant tumors globally, with high morbidity and mortality. Endoplasmic reticulum is a major organelle responsible for protein synthesis, processing, and transport. Endoplasmic reticulum stress (ERS) refers to the abnormal accumulation of unfolded and misfolded proteins in the endoplasmic reticulum, which are involved in tumorigenesis and cancer immunity. Nevertheless, the clinical significance of ERS remains largely unexplored in CRC. METHODS: In present study, we performed an unsupervised clustering to identify two types of ERS-related subtypes [ERS clusters, and ERS-related genes (ERSGs) clusters] in multiple large-scale CRC cohorts. Through the utilization of machine learning techniques, we have successfully developed an uncomplicated yet robust gene scoring system (ERSGs signature). Furthermore, a series of analyses, including GO, KEGG, Tumor Immune Dysfunction and Exclusion (TIDE), the Consensus Molecular Subtypes (CMS), were used to explore the underlying biological differences and clinical significance between these groups. And immunohistochemical and bioinformatics analyses were performed to explore ZNF703, a gene of ERSGs scoring system. RESULTS: We observed significant differences in prognosis and tumor immune status between the ERS clusters as well as ERSGs clusters. And the ERSGs scoring system was an independent risk factor for overall survival; and exhibited distinct tumor immune status in multicenter CRC cohorts. Besides, analyses of TNM stages, CMS groups demonstrated that patients in advanced stage and CMS4 had higher ERSGs scores. In addition, the ERSGs scores inversely correlated with positive ICB response predictors (such as, CD8A, CD274 (PD-L1), and TIS), and directly correlated with negative ICB response predictors (such as, TIDE, T cell Exclusion, COX-IS). Notably, immunohistochemical staining and bioinformatics analyses revealed that ZNF70 correlated with CD3 + and CD8 + T cells infiltration. CONCLUSION: Based on large-scale and multicenter transcriptomic data, our study comprehensively revealed the essential role of ERS in CRC; and constructed a novel ERSGs scoring system to predict the prognosis of patients and the efficacy of ICB treatment. Furthermore, we identified ZNF703 as a potentially promising target for ICB therapy in CRC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04547-z.
format Online
Article
Text
id pubmed-10566095
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105660952023-10-12 Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy Wang, Hufei Li, Zhi Tao, Yangbao Ou, Suwen Ye, Jinhua Ran, Songlin Luo, Kangjia Guan, Zilong Xiang, Jun Yan, Guoqing Wang, Yang Ma, Tianyi Yu, Shan Song, Yanni Huang, Rui J Transl Med Research BACKGROUND: Colorectal cancer (CRC) is one of the most common malignant tumors globally, with high morbidity and mortality. Endoplasmic reticulum is a major organelle responsible for protein synthesis, processing, and transport. Endoplasmic reticulum stress (ERS) refers to the abnormal accumulation of unfolded and misfolded proteins in the endoplasmic reticulum, which are involved in tumorigenesis and cancer immunity. Nevertheless, the clinical significance of ERS remains largely unexplored in CRC. METHODS: In present study, we performed an unsupervised clustering to identify two types of ERS-related subtypes [ERS clusters, and ERS-related genes (ERSGs) clusters] in multiple large-scale CRC cohorts. Through the utilization of machine learning techniques, we have successfully developed an uncomplicated yet robust gene scoring system (ERSGs signature). Furthermore, a series of analyses, including GO, KEGG, Tumor Immune Dysfunction and Exclusion (TIDE), the Consensus Molecular Subtypes (CMS), were used to explore the underlying biological differences and clinical significance between these groups. And immunohistochemical and bioinformatics analyses were performed to explore ZNF703, a gene of ERSGs scoring system. RESULTS: We observed significant differences in prognosis and tumor immune status between the ERS clusters as well as ERSGs clusters. And the ERSGs scoring system was an independent risk factor for overall survival; and exhibited distinct tumor immune status in multicenter CRC cohorts. Besides, analyses of TNM stages, CMS groups demonstrated that patients in advanced stage and CMS4 had higher ERSGs scores. In addition, the ERSGs scores inversely correlated with positive ICB response predictors (such as, CD8A, CD274 (PD-L1), and TIS), and directly correlated with negative ICB response predictors (such as, TIDE, T cell Exclusion, COX-IS). Notably, immunohistochemical staining and bioinformatics analyses revealed that ZNF70 correlated with CD3 + and CD8 + T cells infiltration. CONCLUSION: Based on large-scale and multicenter transcriptomic data, our study comprehensively revealed the essential role of ERS in CRC; and constructed a novel ERSGs scoring system to predict the prognosis of patients and the efficacy of ICB treatment. Furthermore, we identified ZNF703 as a potentially promising target for ICB therapy in CRC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04547-z. BioMed Central 2023-10-11 /pmc/articles/PMC10566095/ /pubmed/37821882 http://dx.doi.org/10.1186/s12967-023-04547-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Hufei
Li, Zhi
Tao, Yangbao
Ou, Suwen
Ye, Jinhua
Ran, Songlin
Luo, Kangjia
Guan, Zilong
Xiang, Jun
Yan, Guoqing
Wang, Yang
Ma, Tianyi
Yu, Shan
Song, Yanni
Huang, Rui
Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy
title Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy
title_full Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy
title_fullStr Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy
title_full_unstemmed Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy
title_short Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy
title_sort characterization of endoplasmic reticulum stress unveils znf703 as a promising target for colorectal cancer immunotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566095/
https://www.ncbi.nlm.nih.gov/pubmed/37821882
http://dx.doi.org/10.1186/s12967-023-04547-z
work_keys_str_mv AT wanghufei characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT lizhi characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT taoyangbao characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT ousuwen characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT yejinhua characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT ransonglin characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT luokangjia characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT guanzilong characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT xiangjun characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT yanguoqing characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT wangyang characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT matianyi characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT yushan characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT songyanni characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy
AT huangrui characterizationofendoplasmicreticulumstressunveilsznf703asapromisingtargetforcolorectalcancerimmunotherapy